Skip to content
healthcare.dev

Paclitaxel protein-bound particles for injectable suspension (albumin-bound)

NDC 68001-651, Paclitaxel, injection, powder, lyophilized, for suspension, from BluePoint Laboratories.

Product NDC
68001-651
Status
Listed
Labeler
BluePoint Laboratories
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA216355
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/68001-651 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • PACLITAXEL100 mg/20mL

Pharmacologic classes

Microtubule Inhibition [PE]; Microtubule Inhibitor [EPC]

Package NDCNDC-11Package
68001-651-37680010651371 VIAL, SINGLE-USE in 1 CARTON (68001-651-37) / 20 mL in 1 VIAL, SINGLE-USE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/36d4a2ed-4b34-4b06-e063-6394a90acc86
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=68001-651

Use it

Look up 68001-651 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/68001-651 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 68001-651. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.